News und Analysen

2025 was a great year for gold stocks, as prices of precious metals soared. Demand came from several quarters, including both the perception of gold as a store of value during troubled times and a

On Dec. 4, 2025, Freddy A. Jimenez, Senior Vice President & General Counsel of Celldex Therapeutics (NASDAQ:CLDX), executed an open-market sale of 4,166 insider shares. See SEC Form 4 filing.

Since 2018, Medicare Advantage Plans have had flexibility in what they cover, as the Bipartisan Budget Act of 2018 allowed plans to expand coverage to include Special Supplemental Benefits for the

On Jan. 5, John M. Leonard, the president and CEO of Intellia Therapeutics (NASDAQ:NTLA), executed an open-market sale of 34,146 directly held shares, totaling $314,484.66, as disclosed in a SEC

On Dec. 23, AnaptysBio (NASDAQ:ANAB) Director J. Anthony Ware executed an open-market sale of 3,900 shares for a transaction value of $193,342.50, representing 28.82% of his direct holdings

On Tuesday, William Guyer, the chief development officer of Corcept Therapeutics (NASDAQ:CORT), exercised and immediately sold 20,000 shares through open-market transactions totaling approximately

Over the long run, the stock market has been the top performer among investment asset classes. Bonds, commodities, foreign currencies, real estate, and other assets have had their moments in the

Paul F. Lizzul, the chief medical officer of AnaptysBio (NASDAQ:ANAB), reported the direct sale of 3,650 shares of the company for a total consideration of approximately $163,191.50 on Thursday, as

Greg Zante, the chief financial officer of Viking Therapeutics (NASDAQ:VKTX), reported the direct sale of 57,661 shares of the biotech in multiple open-market transactions valued at $1.9 million

Dividend investing isn't inherently superior to other styles, as each has its own aims and goals. However, there is something to be said about dividend stocks: Over the long run, they outperform

Medicare Advantage plans are an alternative to traditional Medicare that can provide coverage for more services. The Bipartisan Budget Act of 2018 allowed Advantage Plans to cover things that were

Water is a precious resource that's essential for life. Since the early 1900s, Badger Meter (NYSE: BMI) has been involved in helping utilities and their customers monitor and manage their water use

More often than not, takeover speculation can give a lively boost -- at least in the short term -- to a company's stock. That was the dynamic behind the nearly 11% price gain of Revolution Medicines

The technology sector is an excellent place to find high-growth stocks with promising prospects. However, it is a cyclical sector that doesn't perform as well when the economy tanks. It's critical

The increasing demand for all things artificial intelligence (AI) helped Nvidia emerge out of nowhere to become the world's largest company as measured by market cap. Between the $4.6 trillion

Pfizer's (NYSE: PFE) shares have been southbound for the last three years. And unfortunately for the company, it doesn't look like things will improve significantly in 2026. The pharmaceutical

Capricor Therapeutics (NASDAQ: CAPR) stock rose an incredible 439.4% in December, according to data provided by S&P Global Market Intelligence. The move followed the company's announcement of

The stock of healthcare company Neogen (NASDAQ: NEOG) was the very picture of financial health on Thursday, as its share price ballooned by over 31% that trading session. Investors were clearly

Nvidia (NASDAQ:NVDA), a GPU and AI solutions leader, closed Thursday's session at $185, down 2.17%. Nvidia IPO'd in 1999 and has grown an astounding 450,934% since going public. Trading volume

Nvidia (NASDAQ: NVDA) has been an artificial intelligence (AI) champion since the start of the AI boom. The company got into the space early, focusing the design of its chips to suit this

Sometimes, the investing universe seems like it's upside down. Many of the largest consumer-facing companies make products that fall squarely in the nice-to-have category rather than being

Voyager Technologies (NYSE: VOYG) stock rocketed 8.1% through 11:15 a.m. ET Thursday on a double dose of good news. The biggest: President Trump announced Wednesday he wants to spend $1.5 trillion

Dividend stocks can be the ultimate investments to buy and forget about. They'll generate recurring income for your portfolio, even if you've forgotten you own them. What's important, however, is to